Walden Biosciences Announces Virtual Presentation at Canaccord Genuity 41st Annual Growth Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Walden Biosciences, Inc. (Walden), a biotechnology company focused on transforming the treatment of kidney disease, today announced that Blaine McKee, Ph.D., President and CEO will be presenting at the 41st Annual Canaccord Genuity Virtual Growth Conference. The presentation is scheduled for August 11, 2021 at 11:00am ET. Walden is seeking to develop breakthrough…

Read more

Walden Biosciences Launches to Transform the Treatment of Kidney Disease

Read more